Novoic
Company Overview
Novoic is an AI-enabled software company focused on earlier detection of Alzheimer's disease within 10 minutes through speech analysis. Their technology detects subtle cognitive impairment and Alzheimer's neuropathology by analyzing how people speak, aiming to provide scalable access to early Alzheimer's detection anywhere, especially in underserved communities.
Products and Approach
Novoic offers automated, speech-based cognitive testing that is real-world ready, user-friendly, and works on any smart device. Their solutions include the Novoic Storyteller and Dashboard, leveraging state-of-the-art AI-based speech biomarkers for early detection, AI-assisted triage, and comprehensive patient screening and monitoring at scale.
The company uses advanced AI models, proprietary methods, and large datasets for better algorithms and accurate detection of mild cognitive impairment and Alzheimer's disease. They have run clinical trials with biomarker-confirmed Alzheimer's and employ robust, secure, and compliant software practices ensuring data privacy and integrity.
Collaboration and Reach
Novoic collaborates with over 50 medical centers and institutions, supporting early Alzheimer's detection globally. They emphasize inclusivity and robustness through diverse real-world datasets and are involved in clinical trials and extensive scientific research to validate their technologies.